Characterization of TP53 mutations in Pap test DNA of women with and without serous ovarian carcinoma-Reference-Cited by-同舟云学术

Characterization of TP53 mutations in Pap test DNA of women with and without serous ovarian carcinoma

Published:2020-02 Issue:2 Volume:156 Page:407-414
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Krimmel-Morrison Jeffrey D.,Ghezelayagh Talayeh S.,Lian Shenyi,Zhang Yuezheng,Fredrickson Jeanne,Nachmanson Daniela,Baker Kathryn T.,Radke Marc R.,Hun Enna,Norquist Barbara M.,Emond Mary J.,Swisher Elizabeth M.,Risques Rosa Ana^ORCID

Funder

NIH

Mary Kay Foundation

Rivkin Center for Ovarian Cancer

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference38 articles.

1. Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer;Bowtell;Nat. Rev. Cancer,2015

2. Cancer statistics, 2019;Siegel;CA Cancer J. Clin.,2019

3. Liquid biopsies: genotyping circulating tumor DNA;Diaz;J. Clin. Oncol.,2014

4. Retooling the pap smear for ovarian and endometrial cancer detection;Bakkum-Gamez;Clin. Chem.,2014

5. Rate of pathology from atypical glandular cell pap tests classified by the Bethesda 2001 nomenclature;DeSimone;Obstet. Gynecol.,2006

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increased TP53 somatic evolution in peritoneal washes of individuals with BRCA1 germline mutations;Gynecologic Oncology;2024-11

2. Prevention of Ovarian Cancer: Where are We Now and Where are We Going?;Current Oncology Reports;2024-08-08

3. Single‐molecule epiallelic profiling of DNA derived from routinely collected Pap specimens for noninvasive detection of ovarian cancer;Clinical and Translational Medicine;2024-07-31

4. Cervicovaginal specimen biomarkers for early detection of ovarian and endometrial cancer: A review;Cancer Medicine;2024-07

5. TP53 somatic evolution in cervical liquid-based cytology and blood from individuals with and without ovarian cancer and BRCA1 or BRCA2 germline mutations;Oncogene;2024-06-25